Manufacturing roundup: Lonza to manufacture two new FDA-approved therapies in Houston; Eisai finishes project in Japan
Manufacturing giant Lonza can add more FDA-approved therapies to its repertoire.
The company announced that two therapies manufactured at its Houston site, Zynteglo and Skysona …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.